Tyler L. Dangerfield

Structural basis for mismatch surveillance by CRISPR–Cas9

Jack P. K. Bravo, Mu‐Sen Liu, Grace N. Hibshman et al. · Nature · 2022 · 278 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication

Jack P. K. Bravo, Tyler L. Dangerfield, David W. Taylor et al. · Molecular Cell · 2021 · 134 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +12

Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase

Tyler L. Dangerfield, Nathan Huang, Kenneth A. Johnson · iScience · 2020 · 78 citations · Full text

Life Sciences, Molecular Biology, Enzymology +16

Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9

Grace N. Hibshman, Jack P. K. Bravo, M HOOPER et al. · Nature Communications · 2024 · 57 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

Visible Light Mediated Bidirectional Control over Carbonic Anhydrase Activity in Cells and <i>in Vivo</i> Using Azobenzenesulfonamides

Kanchan Aggarwal, Timothy P. Kuka, Mandira Banik et al. · Journal of the American Chemical Society · 2020 · 55 citations · Full text

Natural Sciences, Biochemistry, Cell Biology +14